Stock Events

Stock Events

Search...

BB Biotech

CHF43.9

164

+CHF0.45+1.04% Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

2.34B

P/E Ratio

7.6

Dividend Yield

4.48%

Dividend

1.96

Upcoming

Dividend Payment

Dividend Payment

Dividends

4.48%Dividend Yield

10Y Growth

N/A

5Y Growth

-6.27%

3Y Growth

-17.07%

1Y Growth

-28.61%

Earnings

26JulExpected

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

Next

999

333

-333

-999

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BION.SW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

iShares Biotechnology ETF, competes by investing in biotech companies, similar to BB Biotech's investment strategy.

SPDR S&P Biotech ETF, competes as it also focuses on biotechnology investments, offering a similar market exposure.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, a direct competitor through its biotech-focused investment portfolio.

ARK Genomic Revolution

ARK Genomic Revolution ETF, competes by investing in the genomic industry, overlapping with BB Biotech's investment interests.

VanEck Vectors Biotech ETF, offers exposure to biotech firms, directly competing with BB Biotech's investment focus.

Principal Healthcare Innovators

Principal Healthcare Innovators Index ETF, competes by focusing on healthcare innovation, including biotech, similar to BB Biotech.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, competes through its focus on biotech and genomic revolution, akin to BB Biotech's strategy.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, competes by investing in small- and mid-cap biotech companies, a market segment also targeted by BB Biotech.

Amplify Treatments Testing and Advancements

ETFMG Treatments, Testing and Advancements ETF, competes by focusing on biotech companies involved in testing and treatments, overlapping with BB Biotech's investment areas.

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares, competes as a leveraged ETF focusing on biotech, offering aggressive exposure similar to BB Biotech's sector focus.

About

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Show more...

CEO

Employees

10

Country

CH

ISIN

CH0038389992

WKN

000A0NFN3

Listings